<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00373958</url>
  </required_header>
  <id_info>
    <org_study_id>6096A1-004</org_study_id>
    <nct_id>NCT00373958</nct_id>
  </id_info>
  <brief_title>Study Comparing 13-valent Pneumococcal Conjugate Vaccine With 7-valent Pneumococcal Conjugate Vaccine</brief_title>
  <official_title>A Phase 3, Randomized, Active-Controlled, Double-blind Trial Evaluating the Safety, Tolerability and Immunologic Noninferiority of a 13-valent Pneumococcal Conjugate Vaccine Compared to a 7-valent Pneumococcal Conjugate Vaccine in Healthy Infants Given With Routine Pediatric Vaccinations in the United States</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety, tolerability, and immunogenicity of the
      13-valent pneumococcal vaccine (13vPnC) compare to the 7-valent pneumococcal vaccine (7vPnC)
      and to compare the immune response to concomitant vaccines administered with 13vPnC and
      7vPnC.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants Achieving Antibody Level ≥0.35 μg/mL in 13vPnC Group Relative to 7vPnC Group After the 3-Dose Infant Series</measure>
    <time_frame>One month after the 3-dose infant series (7 months of age)</time_frame>
    <description>Percentages of Participants achieving World Health Organization (WHO) predefined antibody threshold ≥0.35 μg/mL along with the corresponding 95% CI for the 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Geometric Mean Antibody Concentration in 13vPnC Group Relative to 7vPnC Group 1 Month After the Toddler Dose</measure>
    <time_frame>1 Month After the Toddler Dose</time_frame>
    <description>Antibody concentration/geometric mean concentration as measured by enzyme-linked immunosorbent assay (ELISA) for 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (Serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Achieving Predefined Antibody Levels for Haemophilus Influenzae Type b, Diphtheria Toxoid, and Pertussis Antigens in 13vPnC Group Relative to 7vPnC Group After the Infant Series</measure>
    <time_frame>One Month After the Infant Series (7 months of age)</time_frame>
    <description>Predefined Antibody Levels for Haemophilus Influenzae Type b ([Hib] 0.15 µg/mL or 1.0 µg/mL), Diphtheria Toxoid (0.1 International Units [IU]/mL), and Pertussis antigens (Pertussis filamentous hemagglutinin [FHA] 40.5 Elisa Units [EU]/mL, Pertussis toxoid [PT] 16.5 EU/mL, Pertussis pertactin [PRN] 26 EU/mL).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Reporting Pre-specified Systemic Events</measure>
    <time_frame>Within 7 days after each dose</time_frame>
    <description>Systemic events (any fever [Fv] ≥ 38 degrees Celsius [C], decreased (decr.) appetite, irritability, increased (incr.) sleep, decreased sleep, and hives [urticaria], use of antipyretic medication [med] to treat or prevent symptoms [sx]) were reported using an electronic diary. Participants may be represented in more than 1 category.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Reporting Pre-specified Local Reactions</measure>
    <time_frame>Within 7 days after each dose</time_frame>
    <description>Local reactions were reported using an electronic diary. Tenderness was scaled as Any (tenderness present); Significant ([Sig.], present and interfered with limb movement). Redness and swelling were scaled as Any (redness or swelling present); Mild (0.5 centimeters [cm] to 2.0 cm); Moderate ([Mod.], 2.5 to 7.0 cm); Severe ([Sev.], &gt; 7.0 cm). Participants may have been represented in more than 1 category.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Predefined Antibody Levels for Concomitant Vaccine Antigens Induced by Measles, Mumps, Rubella, Varicella (MMR-V) and Haemophilus Influenzae Type b (Hib)</measure>
    <time_frame>One month after toddler dose (13 to 16 months of age)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Antibody Concentration of Hib PRP in 13vPnC Group Relative to 7vPnC Group After the Toddler Dose</measure>
    <time_frame>one month after the toddler dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Antibody Concentration of Measles, Mumps, and Varicella ELISA in 13vPnC Group Relative to 7vPnC Group After the Toddler Dose</measure>
    <time_frame>one month after the toddler dose</time_frame>
    <description>Normalization was performed for unit of measure &quot;index value&quot; as Index Value of 1.00 = 10 mIU/mL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Antibody Concentration of Rubella in 13vPnC Group Relative to 7vPnC Group After the Toddler Dose</measure>
    <time_frame>one month after the toddler dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Achieving Functional Antibody Titer ≥1:8 as Measured by Opsonophagocytic Activity Assay (OPA) in 13vPnC Group Relative to 7vPnC Group the 3-Dose Infant Series and the Toddler Dose</measure>
    <time_frame>One month after infant series and one month after toddler dose</time_frame>
    <description>Percentage of participants achieving functional antibody titer ≥1:8 as measured by opsonophagocytic activity assay (OPA) along with the corresponding 95% CI for the 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geometric Mean Titer (GMT) as Measured by Opsonophagocytic Activity Assay (OPA) in 13vPnC Group Relative to 7vPnC Group After the 3-Dose Infant Series and the Toddler Dose</measure>
    <time_frame>one month after the infant series and the toddler dose</time_frame>
    <description>Geometric mean titer (GMT) as measured by opsonophagocytic activity assay (OPA) for 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (Serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">666</enrollment>
  <condition>Vaccines, Pneumococcal</condition>
  <arm_group>
    <arm_group_label>13vPnC vaccine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>7vPnC vaccine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>13 valent pneumococcal conjugate vaccine</intervention_name>
    <description>1 single 0.5 mL dose together with a concomitant dose of Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
    <arm_group_label>13vPnC vaccine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>7vPnc pneumococcal conjugate vaccine</intervention_name>
    <description>1 single 0.5 mL dose together with a concomitant dose of Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
    <arm_group_label>7vPnC vaccine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy 2-month-old infants.

          -  Available for the entire study period.

        Exclusion criteria:

          -  Previous vaccination with any vaccine before the start of the study.

          -  Known contraindication to vaccination.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>42 Days</minimum_age>
    <maximum_age>98 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Monitor</last_name>
    <role>Study Director</role>
    <affiliation>Wyeth is now a wholly owned subsidiary of Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Fayetteville</city>
        <state>Arkansas</state>
        <zip>72703</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Downey</city>
        <state>California</state>
        <zip>90242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fontana</city>
        <state>California</state>
        <zip>92335</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Paramount</city>
        <state>California</state>
        <zip>90723</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Centennial</city>
        <state>Colorado</state>
        <zip>80112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Norwich</city>
        <state>Connecticut</state>
        <zip>06360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30062</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Woodstock</city>
        <state>Georgia</state>
        <zip>30189</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Park Ridge</city>
        <state>Illinois</state>
        <zip>60068</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bardstown</city>
        <state>Kentucky</state>
        <zip>40004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45245</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mason</city>
        <state>Ohio</state>
        <zip>45040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Latrobe</city>
        <state>Pennsylvania</state>
        <zip>15650</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburg</city>
        <state>Pennsylvania</state>
        <zip>15241</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sellersville</city>
        <state>Pennsylvania</state>
        <zip>18960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wexford</city>
        <state>Pennsylvania</state>
        <zip>15090</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>The Woodlands</city>
        <state>Texas</state>
        <zip>77380</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Provo</city>
        <state>Utah</state>
        <zip>84604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vienna</city>
        <state>Virginia</state>
        <zip>22180</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2006</study_first_submitted>
  <study_first_submitted_qc>September 7, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2006</study_first_posted>
  <results_first_submitted>March 26, 2010</results_first_submitted>
  <results_first_submitted_qc>January 17, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 21, 2013</results_first_posted>
  <disposition_first_submitted>February 26, 2009</disposition_first_submitted>
  <disposition_first_submitted_qc>September 30, 2009</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">October 2, 2009</disposition_first_posted>
  <last_update_submitted>January 17, 2013</last_update_submitted>
  <last_update_submitted_qc>January 17, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
    <mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited in the United States from September 2006 to January 2008.</recruitment_details>
      <pre_assignment_details>Participants were enrolled into the study according to inclusion/exclusion criteria without a screening period.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>13vPnC</title>
          <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
        </group>
        <group group_id="P2">
          <title>7vPnC</title>
          <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Infant Series</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="334">One participant was prerandomized but not consented.</participants>
                <participants group_id="P2" count="332"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Vaccinated Dose 1</title>
              <participants_list>
                <participants group_id="P1" count="332"/>
                <participants group_id="P2" count="331"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Vaccinated Dose 2</title>
              <participants_list>
                <participants group_id="P1" count="309"/>
                <participants group_id="P2" count="305"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Vaccinated Dose 3</title>
              <participants_list>
                <participants group_id="P1" count="298"/>
                <participants group_id="P2" count="300"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="294"/>
                <participants group_id="P2" count="290"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="42"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failed to return</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost Kaiser coverage</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Child relocated</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Consent was not received</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Toddler Dose</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="294"/>
                <participants group_id="P2" count="290"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Withdrawn After Infant Series</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Vaccinated Toddler Dose</title>
              <participants_list>
                <participants group_id="P1" count="272"/>
                <participants group_id="P2" count="265"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="264"/>
                <participants group_id="P2" count="252"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Failed to return</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawn after infant series</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>13vPnC</title>
          <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
        </group>
        <group group_id="B2">
          <title>7vPnC</title>
          <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="334"/>
            <count group_id="B2" value="332"/>
            <count group_id="B3" value="666"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>months</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.1" spread="0.3"/>
                    <measurement group_id="B2" value="2.1" spread="0.3"/>
                    <measurement group_id="B3" value="2.1" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>patients</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="165"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="304"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="169"/>
                    <measurement group_id="B2" value="193"/>
                    <measurement group_id="B3" value="362"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Achieving Antibody Level ≥0.35 μg/mL in 13vPnC Group Relative to 7vPnC Group After the 3-Dose Infant Series</title>
        <description>Percentages of Participants achieving World Health Organization (WHO) predefined antibody threshold ≥0.35 μg/mL along with the corresponding 95% CI for the 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
        <time_frame>One month after the 3-dose infant series (7 months of age)</time_frame>
        <population>Evaluable immunogenicity (per protocol) population consisting of participants who adhered to the protocol requirements, had valid and determinate assay results, and had no other major protocol violations; (n) = number of participants with a determinate IgG antibody concentration to the given serotype.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
          <group group_id="O2">
            <title>7vPnC</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Antibody Level ≥0.35 μg/mL in 13vPnC Group Relative to 7vPnC Group After the 3-Dose Infant Series</title>
          <description>Percentages of Participants achieving World Health Organization (WHO) predefined antibody threshold ≥0.35 μg/mL along with the corresponding 95% CI for the 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
          <population>Evaluable immunogenicity (per protocol) population consisting of participants who adhered to the protocol requirements, had valid and determinate assay results, and had no other major protocol violations; (n) = number of participants with a determinate IgG antibody concentration to the given serotype.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="252"/>
                <count group_id="O2" value="252"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Common Serotypes - Serotype 4 (n=252,251)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.4" lower_limit="90.9" upper_limit="96.9"/>
                    <measurement group_id="O2" value="98.0" lower_limit="95.4" upper_limit="99.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 6B (n=252,250)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.3" lower_limit="82.5" upper_limit="91.1"/>
                    <measurement group_id="O2" value="92.8" lower_limit="88.9" upper_limit="95.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 9V (n=252,252)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.5" lower_limit="86.2" upper_limit="93.8"/>
                    <measurement group_id="O2" value="98.4" lower_limit="96.0" upper_limit="99.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 14 (n=251,252)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.6" lower_limit="94.9" upper_limit="99.1"/>
                    <measurement group_id="O2" value="97.2" lower_limit="94.4" upper_limit="98.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 18C (n=252,252)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.8" lower_limit="93.8" upper_limit="98.6"/>
                    <measurement group_id="O2" value="98.4" lower_limit="96.0" upper_limit="99.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 19F (n=252,251)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.0" lower_limit="95.4" upper_limit="99.4"/>
                    <measurement group_id="O2" value="97.6" lower_limit="94.9" upper_limit="99.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 23F (n=252,252)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.5" lower_limit="86.2" upper_limit="93.8"/>
                    <measurement group_id="O2" value="94.0" lower_limit="90.4" upper_limit="96.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 1 (n=252,248)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.6" lower_limit="92.3" upper_limit="97.8"/>
                    <measurement group_id="O2" value="1.6" lower_limit="0.4" upper_limit="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 3 (n=249,241)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.5" lower_limit="57.1" upper_limit="69.4"/>
                    <measurement group_id="O2" value="4.6" lower_limit="2.3" upper_limit="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 5 (n=252,197)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.7" lower_limit="85.2" upper_limit="93.1"/>
                    <measurement group_id="O2" value="31.0" lower_limit="24.6" upper_limit="37.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 6A (n=252,240)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.0" lower_limit="92.8" upper_limit="98.1"/>
                    <measurement group_id="O2" value="42.5" lower_limit="36.2" upper_limit="49.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 7F (n=252,248)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.4" lower_limit="96.0" upper_limit="99.6"/>
                    <measurement group_id="O2" value="2.8" lower_limit="1.1" upper_limit="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 19A (n=251,238)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.4" lower_limit="96.0" upper_limit="99.6"/>
                    <measurement group_id="O2" value="86.6" lower_limit="81.6" upper_limit="90.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 4 the difference in percentages between the two groups (13vPnC - 7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the difference between the 2 groups &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-3.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-7.3</ci_lower_limit>
            <ci_upper_limit>-0.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 6B the difference in percentages between the two groups (13vPnC - 7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the difference between the 2 groups &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-5.5</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-10.9</ci_lower_limit>
            <ci_upper_limit>-0.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 9V the difference in percentages between the two groups (13vPnC - 7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the difference between the 2 groups &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-7.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-12.4</ci_lower_limit>
            <ci_upper_limit>-4.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 14 the difference in percentages between the two groups (13vPnC - 7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the difference between the 2 groups &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>0.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-2.7</ci_lower_limit>
            <ci_upper_limit>3.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 18C the difference in percentages between the two groups (13vPnC - 7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the difference between the 2 groups &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-1.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-4.7</ci_lower_limit>
            <ci_upper_limit>1.2</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 19F the difference in percentages between the two groups (13vPnC - 7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the difference between the 2 groups &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>0.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-2.4</ci_lower_limit>
            <ci_upper_limit>3.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 23F the difference in percentages between the two groups (13vPnC - 7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the difference between the 2 groups &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-3.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-8.5</ci_lower_limit>
            <ci_upper_limit>1.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Geometric Mean Antibody Concentration in 13vPnC Group Relative to 7vPnC Group 1 Month After the Toddler Dose</title>
        <description>Antibody concentration/geometric mean concentration as measured by enzyme-linked immunosorbent assay (ELISA) for 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (Serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
        <time_frame>1 Month After the Toddler Dose</time_frame>
        <population>Evaluable immunogenicity (per protocol) population of eligible participants, had valid and determinate assay results, and had no other major protocol violations; (n) = number of participants with a determinate antibody concentration for the specified serotype.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
          <group group_id="O2">
            <title>7vPnC</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Antibody Concentration in 13vPnC Group Relative to 7vPnC Group 1 Month After the Toddler Dose</title>
          <description>Antibody concentration/geometric mean concentration as measured by enzyme-linked immunosorbent assay (ELISA) for 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (Serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
          <population>Evaluable immunogenicity (per protocol) population of eligible participants, had valid and determinate assay results, and had no other major protocol violations; (n) = number of participants with a determinate antibody concentration for the specified serotype.</population>
          <units>μg/mL</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="239"/>
                <count group_id="O2" value="223"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Common Serotypes - Serotype 4 (n=235,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.73" lower_limit="3.28" upper_limit="4.24"/>
                    <measurement group_id="O2" value="5.49" lower_limit="4.91" upper_limit="6.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 6B (n=234,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.53" lower_limit="9.99" upper_limit="13.30"/>
                    <measurement group_id="O2" value="15.63" lower_limit="13.80" upper_limit="17.69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 9V (n=234,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.62" lower_limit="2.32" upper_limit="2.94"/>
                    <measurement group_id="O2" value="3.63" lower_limit="3.25" upper_limit="4.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 14 (n=235,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.11" lower_limit="7.95" upper_limit="10.45"/>
                    <measurement group_id="O2" value="12.72" lower_limit="11.22" upper_limit="14.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 18C (n=236,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.20" lower_limit="2.82" upper_limit="3.64"/>
                    <measurement group_id="O2" value="4.70" lower_limit="4.18" upper_limit="5.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 19F (n=235,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.60" lower_limit="5.85" upper_limit="7.44"/>
                    <measurement group_id="O2" value="5.60" lower_limit="4.87" upper_limit="6.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 23F (n=234,222)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.07" lower_limit="4.41" upper_limit="5.83"/>
                    <measurement group_id="O2" value="7.84" lower_limit="6.91" upper_limit="8.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 1 (n=235,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.06" lower_limit="4.43" upper_limit="5.80"/>
                    <measurement group_id="O2" value="0.03" lower_limit="0.03" upper_limit="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 3 (n=232,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.94" lower_limit="0.83" upper_limit="1.05"/>
                    <measurement group_id="O2" value="0.07" lower_limit="0.05" upper_limit="0.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 5 (n=235,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.72" lower_limit="3.31" upper_limit="4.18"/>
                    <measurement group_id="O2" value="0.55" lower_limit="0.47" upper_limit="0.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 6A (n=235,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.20" lower_limit="7.30" upper_limit="9.20"/>
                    <measurement group_id="O2" value="1.87" lower_limit="1.60" upper_limit="2.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 7F (n=235,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.67" lower_limit="5.01" upper_limit="6.42"/>
                    <measurement group_id="O2" value="0.05" lower_limit="0.04" upper_limit="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 19A (n=236,223)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.55" lower_limit="7.64" upper_limit="9.56"/>
                    <measurement group_id="O2" value="3.54" lower_limit="3.15" upper_limit="3.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 4 the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the GMC ratio (13vPnC/7vPnC) &gt; 0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>0.68</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>0.80</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 6B the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the GMC ratio (13vPnC/7vPnC) &gt; 0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>0.74</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.61</ci_lower_limit>
            <ci_upper_limit>0.89</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 9V the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the GMC ratio (13vPnC/7vPnC) &gt; 0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.62</ci_lower_limit>
            <ci_upper_limit>0.85</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 14 the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the GMC ratio (13vPnC/7vPnC) &gt; 0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>0.72</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.60</ci_lower_limit>
            <ci_upper_limit>0.86</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 18C the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the GMC ratio (13vPnC/7vPnC) &gt; 0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>0.68</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.57</ci_lower_limit>
            <ci_upper_limit>0.81</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 19F the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the GMC ratio (13vPnC/7vPnC) &gt; 0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>1.18</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.98</ci_lower_limit>
            <ci_upper_limit>1.41</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For serotype 23F the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for each common serotype was declared if the lower limit of the 2-sided 95% CI for the GMC ratio (13vPnC/7vPnC) &gt; 0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>0.65</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.54</ci_lower_limit>
            <ci_upper_limit>0.78</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Achieving Predefined Antibody Levels for Haemophilus Influenzae Type b, Diphtheria Toxoid, and Pertussis Antigens in 13vPnC Group Relative to 7vPnC Group After the Infant Series</title>
        <description>Predefined Antibody Levels for Haemophilus Influenzae Type b ([Hib] 0.15 µg/mL or 1.0 µg/mL), Diphtheria Toxoid (0.1 International Units [IU]/mL), and Pertussis antigens (Pertussis filamentous hemagglutinin [FHA] 40.5 Elisa Units [EU]/mL, Pertussis toxoid [PT] 16.5 EU/mL, Pertussis pertactin [PRN] 26 EU/mL).</description>
        <time_frame>One Month After the Infant Series (7 months of age)</time_frame>
        <population>Evaluable immunogenicity (per protocol) population who adhered to the protocol requirements, had valid and determinate assay results, and had no other major protocol violations. (n) = number of participants with a determinate postinfant series antibody concentration to the given concomitant antigen.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
          <group group_id="O2">
            <title>7vPnC</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Predefined Antibody Levels for Haemophilus Influenzae Type b, Diphtheria Toxoid, and Pertussis Antigens in 13vPnC Group Relative to 7vPnC Group After the Infant Series</title>
          <description>Predefined Antibody Levels for Haemophilus Influenzae Type b ([Hib] 0.15 µg/mL or 1.0 µg/mL), Diphtheria Toxoid (0.1 International Units [IU]/mL), and Pertussis antigens (Pertussis filamentous hemagglutinin [FHA] 40.5 Elisa Units [EU]/mL, Pertussis toxoid [PT] 16.5 EU/mL, Pertussis pertactin [PRN] 26 EU/mL).</description>
          <population>Evaluable immunogenicity (per protocol) population who adhered to the protocol requirements, had valid and determinate assay results, and had no other major protocol violations. (n) = number of participants with a determinate postinfant series antibody concentration to the given concomitant antigen.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="252"/>
                <count group_id="O2" value="252"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Hib 0.15 µg/mL (n=237,230)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.9" lower_limit="95.1" upper_limit="99.3"/>
                    <measurement group_id="O2" value="97.8" lower_limit="95.0" upper_limit="99.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hib 1.0 µg/mL (n=237,230)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.6" lower_limit="71.8" upper_limit="82.8"/>
                    <measurement group_id="O2" value="78.3" lower_limit="72.4" upper_limit="83.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diphtheria [IU]/mL (n=233,230)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7" lower_limit="92.2" upper_limit="97.9"/>
                    <measurement group_id="O2" value="96.1" lower_limit="92.7" upper_limit="98.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>FHA [EU]/mL (n=239,240)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.7" lower_limit="93.5" upper_limit="98.5"/>
                    <measurement group_id="O2" value="95.0" lower_limit="91.4" upper_limit="97.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PT [EU]/mL (n=239,240)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.1" lower_limit="90.4" upper_limit="96.8"/>
                    <measurement group_id="O2" value="95.0" lower_limit="91.4" upper_limit="97.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PRN [EU]/mL (n=239,240)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.7" lower_limit="89.9" upper_limit="96.4"/>
                    <measurement group_id="O2" value="95.8" lower_limit="92.5" upper_limit="98.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Haemophilus influenzae type b the difference in percentage between the two groups (13vPnC - 7vPnC) at 0.15μg/mL threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) was &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>0.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-2.9</ci_lower_limit>
            <ci_upper_limit>3.1</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Haemophilus influenzae type b the difference in percentage between the two groups (13vPnC - 7vPnC) at 1.0 μg/mL threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) was &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-0.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-8.3</ci_lower_limit>
            <ci_upper_limit>7.0</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For diphtheria toxoid the difference in percentage between the two groups (13vPnC - 7vPnC) at 0.1 IU/mL threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) was &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-0.4</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-4.3</ci_lower_limit>
            <ci_upper_limit>3.5</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Pertussis FHA the difference in percentage between the two groups (13vPnC - 7vPnC) at 40.5 EU/mL threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) was &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>1.7</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-2.1</ci_lower_limit>
            <ci_upper_limit>5.6</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Pertussis PT the difference in percentage between the two groups (13vPnC - 7vPnC) at 16.5 EU/mL threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) was &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-0.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-5.2</ci_lower_limit>
            <ci_upper_limit>3.4</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Pertussis PRN the difference in percentage between the two groups (13vPnC - 7vPnC) at 26 EU/mL threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) was &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-2.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-6.4</ci_lower_limit>
            <ci_upper_limit>2.0</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving Predefined Antibody Levels for Concomitant Vaccine Antigens Induced by Measles, Mumps, Rubella, Varicella (MMR-V) and Haemophilus Influenzae Type b (Hib)</title>
        <time_frame>One month after toddler dose (13 to 16 months of age)</time_frame>
        <population>Evaluable immunogenicity (per protocol) population of eligible participants who adhered to the protocol requirements, had valid and determinate assay results, and had no other major protocol violations.(n)=number of participants with a determinate posttoddler dose antibody concentration to the given concomitant antigen.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
          <group group_id="O2">
            <title>7vPnC</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Predefined Antibody Levels for Concomitant Vaccine Antigens Induced by Measles, Mumps, Rubella, Varicella (MMR-V) and Haemophilus Influenzae Type b (Hib)</title>
          <population>Evaluable immunogenicity (per protocol) population of eligible participants who adhered to the protocol requirements, had valid and determinate assay results, and had no other major protocol violations.(n)=number of participants with a determinate posttoddler dose antibody concentration to the given concomitant antigen.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="239"/>
                <count group_id="O2" value="223"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Measles ≥1.10 I.V. (n=221,210)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.4" lower_limit="93.0" upper_limit="98.4"/>
                    <measurement group_id="O2" value="97.1" lower_limit="93.9" upper_limit="98.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mumps ≥1.10 I.V. (n=221,210)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.5" lower_limit="70.3" upper_limit="81.9"/>
                    <measurement group_id="O2" value="72.9" lower_limit="66.3" upper_limit="78.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Rubella ≥15 IU/mL (n=209,204)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.9" lower_limit="87.3" upper_limit="95.2"/>
                    <measurement group_id="O2" value="90.7" lower_limit="85.8" upper_limit="94.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Varicella ≥1.09 I.V. (n=221,210)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.7" lower_limit="21.0" upper_limit="33.0"/>
                    <measurement group_id="O2" value="21.9" lower_limit="16.5" upper_limit="28.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hib (PRP) 0.15 µg/mL (n=230,214)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="98.4" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="98.3" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hib (PRP) 1.0 µg/mL (n=230,214)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.4" lower_limit="85.9" upper_limit="93.9"/>
                    <measurement group_id="O2" value="92.1" lower_limit="87.6" upper_limit="95.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Haemophilus influenzae type b the difference in percentage between the two groups (13vPnC - 7vPnC) at 0.15μg/mL threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>0.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-1.6</ci_lower_limit>
            <ci_upper_limit>1.7</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Haemophilus influenzae type b the difference in percentage between the two groups (13vPnC - 7vPnC) at 1.0μg/mL threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-1.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-7.1</ci_lower_limit>
            <ci_upper_limit>3.8</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Measles the difference in percentage between the two groups (13vPnC - 7vPnC) at ≥1.10 I.V. threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) &gt; -5%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>-0.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-4.5</ci_lower_limit>
            <ci_upper_limit>2.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Mumps the difference in percentage between the two groups (13vPnC - 7vPnC) at ≥1.10 I.V. threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) &gt; -5%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>3.6</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-4.7</ci_lower_limit>
            <ci_upper_limit>11.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Rubella the difference in percentage between the two groups (13vPnC - 7vPnC) at ≥15 IU/mL threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) &gt; -5%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>1.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-4.4</ci_lower_limit>
            <ci_upper_limit>6.9</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Varicella the difference in percentage between the two groups (13vPnC - 7vPnC) at ≥1.09 I.V. threshold was calculated.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lowest limit of 2-sided 95% CI for the difference between the 2 groups (13vPnC - 7vPnC) &gt; -10%.</non_inferiority_desc>
            <param_type>Difference</param_type>
            <param_value>4.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-3.4</ci_lower_limit>
            <ci_upper_limit>13.0</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Antibody Concentration of Hib PRP in 13vPnC Group Relative to 7vPnC Group After the Toddler Dose</title>
        <time_frame>one month after the toddler dose</time_frame>
        <population>The all-available toddler immunogenicity population included all subjects who had at least 1 valid and determinate assay result before (excluding postinfant) or after the toddler dose. N = number of participants with a determinate antibody concentration or index value for the specified concomitant antigen.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
          <group group_id="O2">
            <title>7vPnC</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Antibody Concentration of Hib PRP in 13vPnC Group Relative to 7vPnC Group After the Toddler Dose</title>
          <population>The all-available toddler immunogenicity population included all subjects who had at least 1 valid and determinate assay result before (excluding postinfant) or after the toddler dose. N = number of participants with a determinate antibody concentration or index value for the specified concomitant antigen.</population>
          <units>µg/mL</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="248"/>
                <count group_id="O2" value="231"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.84" lower_limit="5.85" upper_limit="7.99"/>
                    <measurement group_id="O2" value="7.30" lower_limit="6.21" upper_limit="8.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Haemophilus influenzae type b (PRP) the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lower bound of the 2-sided, 95% CI for the GMC ratio (13vPnC group/7vPnC group) was &gt;0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.75</ci_lower_limit>
            <ci_upper_limit>1.17</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Antibody Concentration of Measles, Mumps, and Varicella ELISA in 13vPnC Group Relative to 7vPnC Group After the Toddler Dose</title>
        <description>Normalization was performed for unit of measure &quot;index value&quot; as Index Value of 1.00 = 10 mIU/mL.</description>
        <time_frame>one month after the toddler dose</time_frame>
        <population>The all-available toddler immunogenicity population included all subjects who had at least 1 valid and determinate assay result before (excluding postinfant) or after the toddler dose. N = number of participants with a determinate antibody concentration or index value for the specified concomitant antigen.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
          <group group_id="O2">
            <title>7vPnC</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Antibody Concentration of Measles, Mumps, and Varicella ELISA in 13vPnC Group Relative to 7vPnC Group After the Toddler Dose</title>
          <description>Normalization was performed for unit of measure &quot;index value&quot; as Index Value of 1.00 = 10 mIU/mL.</description>
          <population>The all-available toddler immunogenicity population included all subjects who had at least 1 valid and determinate assay result before (excluding postinfant) or after the toddler dose. N = number of participants with a determinate antibody concentration or index value for the specified concomitant antigen.</population>
          <units>index value</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="239"/>
                <count group_id="O2" value="227"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Measles</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.98" lower_limit="1.81" upper_limit="2.16"/>
                    <measurement group_id="O2" value="2.06" lower_limit="1.90" upper_limit="2.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mumps</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.32" lower_limit="1.19" upper_limit="1.46"/>
                    <measurement group_id="O2" value="1.32" lower_limit="1.20" upper_limit="1.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Varicella</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.74" lower_limit="0.69" upper_limit="0.79"/>
                    <measurement group_id="O2" value="0.73" lower_limit="0.69" upper_limit="0.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Measles the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lower bound of the 2-sided, 95% CI for the GMC ratio (13vPnC group/7vPnC group) was &gt;0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>0.96</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.85</ci_lower_limit>
            <ci_upper_limit>1.08</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Mumps the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lower bound of the 2-sided, 95% CI for the GMC ratio (13vPnC group/7vPnC group) was &gt;0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>1.00</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.87</ci_lower_limit>
            <ci_upper_limit>1.14</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Varicella the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lower bound of the 2-sided, 95% CI for the GMC ratio (13vPnC group/7vPnC group) was &gt;0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>1.01</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.92</ci_lower_limit>
            <ci_upper_limit>1.10</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Antibody Concentration of Rubella in 13vPnC Group Relative to 7vPnC Group After the Toddler Dose</title>
        <time_frame>one month after the toddler dose</time_frame>
        <population>The all-available toddler immunogenicity population included all subjects who had at least 1 valid and determinate assay result before (excluding postinfant) or after the toddler dose. N = number of participants with a determinate antibody concentration or index value for the specified concomitant antigen.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
          <group group_id="O2">
            <title>7vPnC</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2, 4, 6 months (infant series). Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Antibody Concentration of Rubella in 13vPnC Group Relative to 7vPnC Group After the Toddler Dose</title>
          <population>The all-available toddler immunogenicity population included all subjects who had at least 1 valid and determinate assay result before (excluding postinfant) or after the toddler dose. N = number of participants with a determinate antibody concentration or index value for the specified concomitant antigen.</population>
          <units>IU/mL</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="227"/>
                <count group_id="O2" value="221"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.53" lower_limit="64.55" upper_limit="90.72"/>
                    <measurement group_id="O2" value="97.69" lower_limit="82.28" upper_limit="115.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For Rubella the GMC ratio (13vPnC/7vPnC) was calculated</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority for concomitant antigens was declared if the lower bound of the 2-sided, 95% CI for the GMC ratio (13vPnC group/7vPnC group) was &gt;0.5 (2-fold criterion).</non_inferiority_desc>
            <param_type>Ratio</param_type>
            <param_value>0.78</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.62</ci_lower_limit>
            <ci_upper_limit>1.00</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Reporting Pre-specified Systemic Events</title>
        <description>Systemic events (any fever [Fv] ≥ 38 degrees Celsius [C], decreased (decr.) appetite, irritability, increased (incr.) sleep, decreased sleep, and hives [urticaria], use of antipyretic medication [med] to treat or prevent symptoms [sx]) were reported using an electronic diary. Participants may be represented in more than 1 category.</description>
        <time_frame>Within 7 days after each dose</time_frame>
        <population>Safety population who received the given vaccination. (n)= number of participants reporting yes for at least 1 day or no for all days.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC Dose 1</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2 months (infant series).</description>
          </group>
          <group group_id="O2">
            <title>7vPnC Dose 1</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2 months (infant series).</description>
          </group>
          <group group_id="O3">
            <title>13vPnC Dose 2</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 4 months (infant series).</description>
          </group>
          <group group_id="O4">
            <title>7vPnC Dose 2</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 4 months (infant series).</description>
          </group>
          <group group_id="O5">
            <title>13vPnC Dose 3</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 6 months (infant series).</description>
          </group>
          <group group_id="O6">
            <title>7vPnC Dose 3</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 6 months (infant series).</description>
          </group>
          <group group_id="O7">
            <title>13vPnC Toddler Dose</title>
            <description>Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
          <group group_id="O8">
            <title>7vPnC Toddler Dose</title>
            <description>Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Reporting Pre-specified Systemic Events</title>
          <description>Systemic events (any fever [Fv] ≥ 38 degrees Celsius [C], decreased (decr.) appetite, irritability, increased (incr.) sleep, decreased sleep, and hives [urticaria], use of antipyretic medication [med] to treat or prevent symptoms [sx]) were reported using an electronic diary. Participants may be represented in more than 1 category.</description>
          <population>Safety population who received the given vaccination. (n)= number of participants reporting yes for at least 1 day or no for all days.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="332"/>
                <count group_id="O2" value="331"/>
                <count group_id="O3" value="309"/>
                <count group_id="O4" value="305"/>
                <count group_id="O5" value="298"/>
                <count group_id="O6" value="300"/>
                <count group_id="O7" value="272"/>
                <count group_id="O8" value="265"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fv≥38°C but ≤39°C(n=196,203,146,151,123,106,99,76</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.0"/>
                    <measurement group_id="O2" value="21.2"/>
                    <measurement group_id="O3" value="43.2"/>
                    <measurement group_id="O4" value="40.4"/>
                    <measurement group_id="O5" value="39.8"/>
                    <measurement group_id="O6" value="37.7"/>
                    <measurement group_id="O7" value="53.5"/>
                    <measurement group_id="O8" value="51.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fv&gt;39°C but ≤40°C(n=177,187,118,123,94,81,61,48)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="2.5"/>
                    <measurement group_id="O4" value="4.9"/>
                    <measurement group_id="O5" value="8.5"/>
                    <measurement group_id="O6" value="2.5"/>
                    <measurement group_id="O7" value="6.6"/>
                    <measurement group_id="O8" value="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fv &gt;40°C (n=174,187,116,121,87,80,60,45)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.8"/>
                    <measurement group_id="O5" value="0.0"/>
                    <measurement group_id="O6" value="1.3"/>
                    <measurement group_id="O7" value="1.7"/>
                    <measurement group_id="O8" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decr. appetite (n=228,238,177,174,147,136,116,110)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.8"/>
                    <measurement group_id="O2" value="45.4"/>
                    <measurement group_id="O3" value="59.9"/>
                    <measurement group_id="O4" value="52.3"/>
                    <measurement group_id="O5" value="59.2"/>
                    <measurement group_id="O6" value="59.6"/>
                    <measurement group_id="O7" value="65.5"/>
                    <measurement group_id="O8" value="73.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Irritability (n=289,290,236,236,216,218,199,175)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.6"/>
                    <measurement group_id="O2" value="85.9"/>
                    <measurement group_id="O3" value="89.8"/>
                    <measurement group_id="O4" value="91.5"/>
                    <measurement group_id="O5" value="88.4"/>
                    <measurement group_id="O6" value="92.2"/>
                    <measurement group_id="O7" value="92.0"/>
                    <measurement group_id="O8" value="93.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Incr. sleep (n=268,270,203,200,164,149,115,109)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.5"/>
                    <measurement group_id="O2" value="78.5"/>
                    <measurement group_id="O3" value="79.3"/>
                    <measurement group_id="O4" value="73.5"/>
                    <measurement group_id="O5" value="71.3"/>
                    <measurement group_id="O6" value="69.8"/>
                    <measurement group_id="O7" value="70.4"/>
                    <measurement group_id="O8" value="74.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decr. sleep (n=221,236,169,172,154,134,113,95)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.7"/>
                    <measurement group_id="O2" value="47.9"/>
                    <measurement group_id="O3" value="49.1"/>
                    <measurement group_id="O4" value="55.8"/>
                    <measurement group_id="O5" value="60.4"/>
                    <measurement group_id="O6" value="63.4"/>
                    <measurement group_id="O7" value="58.4"/>
                    <measurement group_id="O8" value="64.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hives (urticaria) (n=178,188,118,120,89,79,62,47)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                    <measurement group_id="O2" value="1.1"/>
                    <measurement group_id="O3" value="2.5"/>
                    <measurement group_id="O4" value="0.0"/>
                    <measurement group_id="O5" value="4.5"/>
                    <measurement group_id="O6" value="0.0"/>
                    <measurement group_id="O7" value="4.8"/>
                    <measurement group_id="O8" value="6.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Med-treat sx (n=257,266,221,221,203,187,162,138)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.6"/>
                    <measurement group_id="O2" value="71.8"/>
                    <measurement group_id="O3" value="82.4"/>
                    <measurement group_id="O4" value="81.9"/>
                    <measurement group_id="O5" value="82.3"/>
                    <measurement group_id="O6" value="85.6"/>
                    <measurement group_id="O7" value="84.0"/>
                    <measurement group_id="O8" value="87.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Med-prevent sx (n=272,274,233,231,202,189,164,162)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.0"/>
                    <measurement group_id="O2" value="74.8"/>
                    <measurement group_id="O3" value="86.7"/>
                    <measurement group_id="O4" value="83.5"/>
                    <measurement group_id="O5" value="81.2"/>
                    <measurement group_id="O6" value="84.1"/>
                    <measurement group_id="O7" value="88.4"/>
                    <measurement group_id="O8" value="90.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants Reporting Pre-specified Local Reactions</title>
        <description>Local reactions were reported using an electronic diary. Tenderness was scaled as Any (tenderness present); Significant ([Sig.], present and interfered with limb movement). Redness and swelling were scaled as Any (redness or swelling present); Mild (0.5 centimeters [cm] to 2.0 cm); Moderate ([Mod.], 2.5 to 7.0 cm); Severe ([Sev.], &gt; 7.0 cm). Participants may have been represented in more than 1 category.</description>
        <time_frame>Within 7 days after each dose</time_frame>
        <population>Safety population who received the given vaccination. (n)= number of participants reporting yes for at least 1 day or no for all days.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC Dose 1</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2 months (infant series).</description>
          </group>
          <group group_id="O2">
            <title>7vPnC Dose 1</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2 months (infant series).</description>
          </group>
          <group group_id="O3">
            <title>13vPnC Dose 2</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 4 months (infant series).</description>
          </group>
          <group group_id="O4">
            <title>7vPnC Dose 2</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 4 months (infant series).</description>
          </group>
          <group group_id="O5">
            <title>13vPnC Dose 3</title>
            <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 6 months (infant series).</description>
          </group>
          <group group_id="O6">
            <title>7vPnC Dose 3</title>
            <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 6 months (infant series).</description>
          </group>
          <group group_id="O7">
            <title>13vPnC Toddler Dose</title>
            <description>Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
          <group group_id="O8">
            <title>7vPnC Toddler Series</title>
            <description>Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Reporting Pre-specified Local Reactions</title>
          <description>Local reactions were reported using an electronic diary. Tenderness was scaled as Any (tenderness present); Significant ([Sig.], present and interfered with limb movement). Redness and swelling were scaled as Any (redness or swelling present); Mild (0.5 centimeters [cm] to 2.0 cm); Moderate ([Mod.], 2.5 to 7.0 cm); Severe ([Sev.], &gt; 7.0 cm). Participants may have been represented in more than 1 category.</description>
          <population>Safety population who received the given vaccination. (n)= number of participants reporting yes for at least 1 day or no for all days.</population>
          <units>Percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="332"/>
                <count group_id="O2" value="331"/>
                <count group_id="O3" value="309"/>
                <count group_id="O4" value="305"/>
                <count group_id="O5" value="298"/>
                <count group_id="O6" value="300"/>
                <count group_id="O7" value="272"/>
                <count group_id="O8" value="265"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Tenderness-Any (n=264,270,200,216,178,173,149,147)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.7"/>
                    <measurement group_id="O2" value="72.2"/>
                    <measurement group_id="O3" value="77.0"/>
                    <measurement group_id="O4" value="75.9"/>
                    <measurement group_id="O5" value="78.7"/>
                    <measurement group_id="O6" value="80.9"/>
                    <measurement group_id="O7" value="81.2"/>
                    <measurement group_id="O8" value="84.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Tenderness-Sig. (n=182,195,123,131,91,86,65,49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.7"/>
                    <measurement group_id="O2" value="9.2"/>
                    <measurement group_id="O3" value="10.6"/>
                    <measurement group_id="O4" value="11.5"/>
                    <measurement group_id="O5" value="8.8"/>
                    <measurement group_id="O6" value="9.3"/>
                    <measurement group_id="O7" value="15.4"/>
                    <measurement group_id="O8" value="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling-Any (n=201,216,141,146,116,103,91,73)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.4"/>
                    <measurement group_id="O2" value="23.6"/>
                    <measurement group_id="O3" value="31.2"/>
                    <measurement group_id="O4" value="29.5"/>
                    <measurement group_id="O5" value="37.9"/>
                    <measurement group_id="O6" value="36.9"/>
                    <measurement group_id="O7" value="44.0"/>
                    <measurement group_id="O8" value="50.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling-Mild (n=199,212,141,142,113,103,90,71)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.1"/>
                    <measurement group_id="O2" value="21.2"/>
                    <measurement group_id="O3" value="29.8"/>
                    <measurement group_id="O4" value="26.1"/>
                    <measurement group_id="O5" value="35.4"/>
                    <measurement group_id="O6" value="36.9"/>
                    <measurement group_id="O7" value="43.3"/>
                    <measurement group_id="O8" value="46.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling-Mod. (n=176,193,118,126,91,82,68,49)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.8"/>
                    <measurement group_id="O2" value="5.2"/>
                    <measurement group_id="O3" value="5.1"/>
                    <measurement group_id="O4" value="7.1"/>
                    <measurement group_id="O5" value="6.6"/>
                    <measurement group_id="O6" value="6.1"/>
                    <measurement group_id="O7" value="14.7"/>
                    <measurement group_id="O8" value="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Swelling-Sev. (n=172,187,116,120,87,79,59,44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                    <measurement group_id="O5" value="0.0"/>
                    <measurement group_id="O6" value="0.0"/>
                    <measurement group_id="O7" value="0.0"/>
                    <measurement group_id="O8" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness-Any (n=202,223,155,164,131,118,103,87)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.6"/>
                    <measurement group_id="O2" value="32.3"/>
                    <measurement group_id="O3" value="45.2"/>
                    <measurement group_id="O4" value="37.8"/>
                    <measurement group_id="O5" value="48.9"/>
                    <measurement group_id="O6" value="50.0"/>
                    <measurement group_id="O7" value="54.4"/>
                    <measurement group_id="O8" value="65.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness-Mild (n=200,220,155,162,128,117,102,85)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.5"/>
                    <measurement group_id="O2" value="31.4"/>
                    <measurement group_id="O3" value="44.5"/>
                    <measurement group_id="O4" value="37.0"/>
                    <measurement group_id="O5" value="47.7"/>
                    <measurement group_id="O6" value="48.7"/>
                    <measurement group_id="O7" value="53.9"/>
                    <measurement group_id="O8" value="63.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness-Mod. (n=177,191,117,124,91,80,62,50)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5"/>
                    <measurement group_id="O2" value="2.6"/>
                    <measurement group_id="O3" value="1.7"/>
                    <measurement group_id="O4" value="3.2"/>
                    <measurement group_id="O5" value="5.5"/>
                    <measurement group_id="O6" value="5.0"/>
                    <measurement group_id="O7" value="8.1"/>
                    <measurement group_id="O8" value="14.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Redness-Sev. (n=173,186,116,120,87,79,59,44)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.0"/>
                    <measurement group_id="O2" value="0.0"/>
                    <measurement group_id="O3" value="0.0"/>
                    <measurement group_id="O4" value="0.0"/>
                    <measurement group_id="O5" value="0.0"/>
                    <measurement group_id="O6" value="0.0"/>
                    <measurement group_id="O7" value="0.0"/>
                    <measurement group_id="O8" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Achieving Functional Antibody Titer ≥1:8 as Measured by Opsonophagocytic Activity Assay (OPA) in 13vPnC Group Relative to 7vPnC Group the 3-Dose Infant Series and the Toddler Dose</title>
        <description>Percentage of participants achieving functional antibody titer ≥1:8 as measured by opsonophagocytic activity assay (OPA) along with the corresponding 95% CI for the 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
        <time_frame>One month after infant series and one month after toddler dose</time_frame>
        <population>Evaluable immunogenicity (per protocol) population of eligible participants who adhered to the protocol requirements, had valid and determinate assay results, and had no other major protocol violations;(n) = number of participants with a determinate postinfant series OPA antibody titer to the given serotype.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC After Infant Series</title>
            <description>Participants received 1 single 0.5 mL dose together with a concomitant dose of Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
          </group>
          <group group_id="O2">
            <title>7vPnC After Infant Series</title>
            <description>Participants received 1 single 0.5 mL dose together with a concomitant dose of Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
          </group>
          <group group_id="O3">
            <title>13vPnC After Toddler Dose</title>
            <description>Participants received 1 single 0.5 mL dose together with a concomitant dose of Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
          </group>
          <group group_id="O4">
            <title>7vPnC After Toddler Dose</title>
            <description>Participants received 1 single 0.5 mL dose together with a concomitant dose of Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Achieving Functional Antibody Titer ≥1:8 as Measured by Opsonophagocytic Activity Assay (OPA) in 13vPnC Group Relative to 7vPnC Group the 3-Dose Infant Series and the Toddler Dose</title>
          <description>Percentage of participants achieving functional antibody titer ≥1:8 as measured by opsonophagocytic activity assay (OPA) along with the corresponding 95% CI for the 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
          <population>Evaluable immunogenicity (per protocol) population of eligible participants who adhered to the protocol requirements, had valid and determinate assay results, and had no other major protocol violations;(n) = number of participants with a determinate postinfant series OPA antibody titer to the given serotype.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="252"/>
                <count group_id="O2" value="252"/>
                <count group_id="O3" value="239"/>
                <count group_id="O4" value="223"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Common Serotypes - Serotype 4 (n=92,92,88,92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.8" lower_limit="92.4" upper_limit="99.7"/>
                    <measurement group_id="O2" value="98.9" lower_limit="94.1" upper_limit="100.0"/>
                    <measurement group_id="O3" value="98.9" lower_limit="93.8" upper_limit="100.0"/>
                    <measurement group_id="O4" value="98.9" lower_limit="94.1" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 6B (n=94,94,92,95)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.9" lower_limit="94.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                    <measurement group_id="O3" value="98.9" lower_limit="94.1" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 9V (n=93,94,90,94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="96.1" upper_limit="100.0"/>
                    <measurement group_id="O2" value="98.9" lower_limit="94.2" upper_limit="100.0"/>
                    <measurement group_id="O3" value="98.9" lower_limit="94.0" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 14 (n=94,94,92,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="96.1" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 18C (n=94,94,91,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                    <measurement group_id="O3" value="98.9" lower_limit="94.0" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 19F (n=94,94,92,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.4" lower_limit="82.6" upper_limit="95.5"/>
                    <measurement group_id="O2" value="92.6" lower_limit="85.3" upper_limit="97.0"/>
                    <measurement group_id="O3" value="96.7" lower_limit="90.8" upper_limit="99.3"/>
                    <measurement group_id="O4" value="94.8" lower_limit="88.3" upper_limit="98.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 23F (n=94,94,90,92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.9" lower_limit="94.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="98.9" lower_limit="94.2" upper_limit="100.0"/>
                    <measurement group_id="O3" value="98.9" lower_limit="94.0" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="96.1" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 1 (n=92,92,89,92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.9" lower_limit="94.1" upper_limit="100.0"/>
                    <measurement group_id="O2" value="9.8" lower_limit="4.6" upper_limit="17.8"/>
                    <measurement group_id="O3" value="98.9" lower_limit="93.9" upper_limit="100.0"/>
                    <measurement group_id="O4" value="12.0" lower_limit="6.1" upper_limit="20.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 3 (n=94,94,91,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="96.8" lower_limit="91.0" upper_limit="99.3"/>
                    <measurement group_id="O2" value="21.3" lower_limit="13.5" upper_limit="30.9"/>
                    <measurement group_id="O3" value="97.8" lower_limit="92.3" upper_limit="99.7"/>
                    <measurement group_id="O4" value="43.8" lower_limit="33.6" upper_limit="54.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 5 (n=91,93,91,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3" lower_limit="84.8" upper_limit="96.9"/>
                    <measurement group_id="O2" value="2.2" lower_limit="0.3" upper_limit="7.6"/>
                    <measurement group_id="O3" value="98.9" lower_limit="94.0" upper_limit="100.0"/>
                    <measurement group_id="O4" value="5.2" lower_limit="1.7" upper_limit="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 6A (n=94,94,92,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="77.7" lower_limit="67.9" upper_limit="85.6"/>
                    <measurement group_id="O3" value="98.9" lower_limit="94.1" upper_limit="100.0"/>
                    <measurement group_id="O4" value="94.8" lower_limit="88.3" upper_limit="98.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 7F (n=94,89,91,92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="96.2" upper_limit="100.0"/>
                    <measurement group_id="O2" value="76.4" lower_limit="66.2" upper_limit="84.8"/>
                    <measurement group_id="O3" value="100.0" lower_limit="96.0" upper_limit="100.0"/>
                    <measurement group_id="O4" value="80.4" lower_limit="70.9" upper_limit="88.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes-Serotype 19A (n=93,92,91,94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.4" lower_limit="83.8" upper_limit="96.2"/>
                    <measurement group_id="O2" value="16.3" lower_limit="9.4" upper_limit="25.5"/>
                    <measurement group_id="O3" value="97.8" lower_limit="92.3" upper_limit="99.7"/>
                    <measurement group_id="O4" value="53.2" lower_limit="42.6" upper_limit="63.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Geometric Mean Titer (GMT) as Measured by Opsonophagocytic Activity Assay (OPA) in 13vPnC Group Relative to 7vPnC Group After the 3-Dose Infant Series and the Toddler Dose</title>
        <description>Geometric mean titer (GMT) as measured by opsonophagocytic activity assay (OPA) for 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (Serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
        <time_frame>one month after the infant series and the toddler dose</time_frame>
        <population>Evaluable immunogenicity (per protocol) population of eligible subjects who adhered to the protocol requirements, had valid and determinate assay results, and had no other major protocol violations, (n) = number of participants with a determinate antibody titer for the specified serotype.</population>
        <group_list>
          <group group_id="O1">
            <title>13vPnC After the Infant Series</title>
            <description>Subjects received 1 single 0.5 mL dose of 13vPnC coadministered with Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
          </group>
          <group group_id="O2">
            <title>7vPnC After the Infant Series</title>
            <description>Subjects received 1 single 0.5 mL dose of 7vPnC coadministered with Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
          </group>
          <group group_id="O3">
            <title>13vPnC After the Toddler Dose</title>
            <description>Subjects received 1 single 0.5 mL dose of 13vPnC coadministered with Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
          </group>
          <group group_id="O4">
            <title>7vPnC After the Toddler Dose</title>
            <description>Subjects received 1 single 0.5 mL dose of 7vPnC coadministered with Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Geometric Mean Titer (GMT) as Measured by Opsonophagocytic Activity Assay (OPA) in 13vPnC Group Relative to 7vPnC Group After the 3-Dose Infant Series and the Toddler Dose</title>
          <description>Geometric mean titer (GMT) as measured by opsonophagocytic activity assay (OPA) for 7 common pneumococcal serotypes (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) and 6 additional pneumococcal serotypes specific to 13vPnC (Serotypes 1, 3, 5, 6A, 7F, and 19A) are presented.</description>
          <population>Evaluable immunogenicity (per protocol) population of eligible subjects who adhered to the protocol requirements, had valid and determinate assay results, and had no other major protocol violations, (n) = number of participants with a determinate antibody titer for the specified serotype.</population>
          <units>titer</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="252"/>
                <count group_id="O2" value="252"/>
                <count group_id="O3" value="239"/>
                <count group_id="O4" value="223"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Common Serotypes -Serotype 4 (n=92,92,88,92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="359.32" lower_limit="276.04" upper_limit="467.72"/>
                    <measurement group_id="O2" value="535.68" lower_limit="421.13" upper_limit="681.37"/>
                    <measurement group_id="O3" value="1179.98" lower_limit="847.34" upper_limit="1643.20"/>
                    <measurement group_id="O4" value="1492.46" lower_limit="1114.40" upper_limit="1998.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 6B (n=94,94,92,95)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1054.65" lower_limit="817.34" upper_limit="1360.87"/>
                    <measurement group_id="O2" value="1513.66" lower_limit="1206.64" upper_limit="1898.81"/>
                    <measurement group_id="O3" value="3099.51" lower_limit="2337.02" upper_limit="4110.79"/>
                    <measurement group_id="O4" value="4066.22" lower_limit="3243.42" upper_limit="5097.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 9V (n=93,94,90,94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4035.40" lower_limit="2932.68" upper_limit="5552.75"/>
                    <measurement group_id="O2" value="3259.01" lower_limit="2288.43" upper_limit="4641.25"/>
                    <measurement group_id="O3" value="11856.03" lower_limit="8809.85" upper_limit="15955.49"/>
                    <measurement group_id="O4" value="18032.33" lower_limit="14124.99" upper_limit="23020.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 14 (n=94,94,92,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1240.41" lower_limit="934.93" upper_limit="1645.69"/>
                    <measurement group_id="O2" value="1480.55" lower_limit="1133.40" upper_limit="1934.02"/>
                    <measurement group_id="O3" value="2002.23" lower_limit="1452.54" upper_limit="2759.93"/>
                    <measurement group_id="O4" value="2365.87" lower_limit="1870.56" upper_limit="2992.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 18C (n=94,94,91,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="275.59" lower_limit="210.33" upper_limit="361.10"/>
                    <measurement group_id="O2" value="375.64" lower_limit="291.68" upper_limit="483.75"/>
                    <measurement group_id="O3" value="993.27" lower_limit="754.08" upper_limit="1308.33"/>
                    <measurement group_id="O4" value="1722.16" lower_limit="1326.59" upper_limit="2235.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 19F (n=94,94,92,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.42" lower_limit="40.20" upper_limit="73.65"/>
                    <measurement group_id="O2" value="44.92" lower_limit="33.90" upper_limit="59.52"/>
                    <measurement group_id="O3" value="199.65" lower_limit="144.22" upper_limit="276.38"/>
                    <measurement group_id="O4" value="167.20" lower_limit="121.35" upper_limit="230.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Common Serotypes - Serotype 23F (n=94,94,90,92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="791.07" lower_limit="604.96" upper_limit="1034.44"/>
                    <measurement group_id="O2" value="923.56" lower_limit="708.59" upper_limit="1203.74"/>
                    <measurement group_id="O3" value="2723.25" lower_limit="1960.67" upper_limit="3782.41"/>
                    <measurement group_id="O4" value="4981.68" lower_limit="3885.71" upper_limit="6386.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 1 (n=92,92,89,92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.83" lower_limit="38.84" upper_limit="69.16"/>
                    <measurement group_id="O2" value="4.41" lower_limit="4.06" upper_limit="4.80"/>
                    <measurement group_id="O3" value="164.23" lower_limit="113.83" upper_limit="236.93"/>
                    <measurement group_id="O4" value="5.01" lower_limit="4.22" upper_limit="5.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 3 (n=94,94,91,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120.67" lower_limit="92.38" upper_limit="157.62"/>
                    <measurement group_id="O2" value="6.70" lower_limit="5.27" upper_limit="8.52"/>
                    <measurement group_id="O3" value="380.41" lower_limit="300.19" upper_limit="482.08"/>
                    <measurement group_id="O4" value="11.81" lower_limit="8.68" upper_limit="16.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 5 (n=91,93,91,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.86" lower_limit="67.10" upper_limit="123.02"/>
                    <measurement group_id="O2" value="4.15" lower_limit="3.94" upper_limit="4.38"/>
                    <measurement group_id="O3" value="300.41" lower_limit="229.39" upper_limit="393.40"/>
                    <measurement group_id="O4" value="4.69" lower_limit="3.99" upper_limit="5.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 6A (n=94,94,92,96)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="979.68" lower_limit="783.04" upper_limit="1225.71"/>
                    <measurement group_id="O2" value="100.35" lower_limit="66.22" upper_limit="152.08"/>
                    <measurement group_id="O3" value="2241.79" lower_limit="1706.71" upper_limit="2944.63"/>
                    <measurement group_id="O4" value="538.54" lower_limit="374.83" upper_limit="773.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes - Serotype 7F (n=94,89,91,92)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9493.77" lower_limit="7339.13" upper_limit="12280.98"/>
                    <measurement group_id="O2" value="128.00" lower_limit="79.55" upper_limit="205.97"/>
                    <measurement group_id="O3" value="11629.44" lower_limit="9053.62" upper_limit="14938.11"/>
                    <measurement group_id="O4" value="267.84" lower_limit="164.49" upper_limit="436.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Additional Serotypes-Serotype 19A (n=93,92,91,94)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="151.94" lower_limit="105.16" upper_limit="219.52"/>
                    <measurement group_id="O2" value="6.53" lower_limit="5.01" upper_limit="8.50"/>
                    <measurement group_id="O3" value="1024.00" lower_limit="774.12" upper_limit="1354.54"/>
                    <measurement group_id="O4" value="28.65" lower_limit="18.58" upper_limit="44.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were collected throughout the study.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>13vPnC Infant Series</title>
          <description>Participants received one single 0.5 mL dose of 13-valent pneumococcal conjugate vaccine (13vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2 months (infant series).</description>
        </group>
        <group group_id="E2">
          <title>7vPnC Infant Series</title>
          <description>Participants received one single 0.5 mL dose of 7-valent pneumococcal conjugate vaccine (7vPnC) coadministered with Haemophilus b Conjugate Vaccine (ActHIB) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined (Pediarix) at 2 months (infant series).</description>
        </group>
        <group group_id="E3">
          <title>13vPnC Post Infant Series</title>
          <description>Participants received 1 single 0.5 mL dose together with a concomitant dose of Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
        </group>
        <group group_id="E4">
          <title>7vPnC Post Infant Series</title>
          <description>Participants received 1 single 0.5 mL dose together with a concomitant dose of Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
        </group>
        <group group_id="E5">
          <title>13vPnC Toddler Series</title>
          <description>Participants received one single 0.5 mL dose of 13vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
        </group>
        <group group_id="E6">
          <title>7vPnC Toddler Series</title>
          <description>Participants received one single 0.5 mL dose of 7vPnC coadministered with measles, mumps, rubella varicella vaccine live (ProQuad), Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PedvaxHIB), and Hepatitis A Vaccine, Inactivated (VAQTA) at 12-15 months of age (toddler dose).</description>
        </group>
        <group group_id="E7">
          <title>13vPnC 6-Month Follow-up</title>
          <description>Participants received 1 single 0.5 mL dose together with a concomitant dose of Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
        </group>
        <group group_id="E8">
          <title>7vPnC 6-Month Follow-up</title>
          <description>Participants received 1 single 0.5 mL dose together with a concomitant dose of Pediarix and ActHIB at the 2-, 4-, and 6-month visits and ProQuad, PedvaxHIB, and VAQTA at the 12-15 month visit.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="9" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Thromboycytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Congenital megacolon</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Selective IgA immunodeficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Croup infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Pneumonia respiratory syncytial viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Pneumonia viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus bronchiolitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Varicella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental exposure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Near drowning</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Skull fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Nephroblastoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Febrile convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Postical paralysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Apnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Bronchial hyperreactivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Status asthmaticus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>Local Reactions</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="272" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="263" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="31" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="29" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="183" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="163" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="11" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Neutrophilia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Plagiocephaly</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Ankyloglossia congenital</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Macrocephaly</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dermoid cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Patent ductus arteriosus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Pectus excavatum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Phimosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Pilonidal cyst congenital</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Thalassaemia trait</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Atrial septal defect</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Hip dysplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Sickle cell trait</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Haemoglobin C trait</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Talipes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Tibial torsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Cerumen impaction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Middle ear effusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Eustachian tube dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Tympanic membrane perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Precocious puberty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Eye discharge</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Eye swelling</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Strabismus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Lacrimation increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dacryostenosis acquired</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Eyelid irritation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Scleral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Teething</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Anal fissure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Infantile spitting up</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Abdominal wall disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Gingival cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rectal fissure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Stomach discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Anal skin tags</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Enamel anomaly</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Injection site bruising</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Injection site induration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Xerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Developmental delay</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Injection site rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Injection site reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever ≥38°C but ≤39°C</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Fever ≥38 degrees C but ≤39 degrees C</description>
                <counts group_id="E1" subjects_affected="47" subjects_at_risk="196"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="203"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="53" subjects_at_risk="99"/>
                <counts group_id="E6" subjects_affected="39" subjects_at_risk="76"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever ≥38°C but ≤39°C</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Fever ≥38 degrees C but ≤39 degrees C</description>
                <counts group_id="E1" subjects_affected="63" subjects_at_risk="146"/>
                <counts group_id="E2" subjects_affected="61" subjects_at_risk="151"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever ≥38°C but ≤39°C</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Fever ≥38 degrees C but ≤39 degrees C</description>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="123"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="106"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever &gt;39°C but ≤40°C</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Fever &gt;39 degrees C but ≤40 degrees C</description>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="177"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="187"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="61"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="48"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever &gt;39°C but ≤40°C</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Fever &gt;39 degrees C but ≤40 degrees C</description>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="94"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="81"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever &gt;40°C</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Fever &gt;40 degrees C</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="174"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="187"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="60"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="45"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever &gt;40°C</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Fever &gt;40 degrees C</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="116"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="121"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever &gt;40°C</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Fever &gt;40 degrees C</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Decreased appetite</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Decreased appetite</description>
                <counts group_id="E1" subjects_affected="125" subjects_at_risk="228"/>
                <counts group_id="E2" subjects_affected="108" subjects_at_risk="238"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="76" subjects_at_risk="116"/>
                <counts group_id="E6" subjects_affected="81" subjects_at_risk="110"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Decreased appetite</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Decreased appetite</description>
                <counts group_id="E1" subjects_affected="106" subjects_at_risk="177"/>
                <counts group_id="E2" subjects_affected="91" subjects_at_risk="174"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Decreased appetite</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Decreased appetite</description>
                <counts group_id="E1" subjects_affected="87" subjects_at_risk="147"/>
                <counts group_id="E2" subjects_affected="81" subjects_at_risk="136"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Irritability</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Irritability</description>
                <counts group_id="E1" subjects_affected="259" subjects_at_risk="289"/>
                <counts group_id="E2" subjects_affected="249" subjects_at_risk="290"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="183" subjects_at_risk="199"/>
                <counts group_id="E6" subjects_affected="163" subjects_at_risk="175"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Irritability</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Irritability</description>
                <counts group_id="E1" subjects_affected="212" subjects_at_risk="236"/>
                <counts group_id="E2" subjects_affected="216" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Irritability</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Irritability</description>
                <counts group_id="E1" subjects_affected="191" subjects_at_risk="216"/>
                <counts group_id="E2" subjects_affected="201" subjects_at_risk="218"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Increased sleep</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Increased sleep</description>
                <counts group_id="E1" subjects_affected="213" subjects_at_risk="268"/>
                <counts group_id="E2" subjects_affected="212" subjects_at_risk="270"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="81" subjects_at_risk="115"/>
                <counts group_id="E6" subjects_affected="81" subjects_at_risk="109"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Increased sleep</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Increased sleep</description>
                <counts group_id="E1" subjects_affected="161" subjects_at_risk="203"/>
                <counts group_id="E2" subjects_affected="147" subjects_at_risk="200"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Increased sleep</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Increased sleep</description>
                <counts group_id="E1" subjects_affected="117" subjects_at_risk="164"/>
                <counts group_id="E2" subjects_affected="104" subjects_at_risk="149"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Decreased sleep</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Decreased sleep</description>
                <counts group_id="E1" subjects_affected="101" subjects_at_risk="221"/>
                <counts group_id="E2" subjects_affected="113" subjects_at_risk="236"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="66" subjects_at_risk="113"/>
                <counts group_id="E6" subjects_affected="61" subjects_at_risk="95"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Decreased sleep</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Decreased sleep</description>
                <counts group_id="E1" subjects_affected="83" subjects_at_risk="169"/>
                <counts group_id="E2" subjects_affected="96" subjects_at_risk="172"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Decreased sleep</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Decreased sleep</description>
                <counts group_id="E1" subjects_affected="93" subjects_at_risk="154"/>
                <counts group_id="E2" subjects_affected="85" subjects_at_risk="134"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Hives (urticaria)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Hives (urticaria)</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="178"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="188"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="62"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Hives (urticaria)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Hives (urticaria)</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="118"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Hives (urticaria)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Hives (urticaria)</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="89"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergy to metals</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Food allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Milk allergy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="131" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="131" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="21" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="24" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Otitis media</sub_title>
                <counts group_id="E1" subjects_affected="94" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="77" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="23" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="23" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Bronchiolitis</sub_title>
                <counts group_id="E1" subjects_affected="52" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="49" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Otitis media acute</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Candida nappy rash</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Croup infectious</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Viral skin infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Respiratory syncytial virus bronchiolitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Gastroenteritis rotavirus</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Skin candida</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Conjunctivitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Impetigo</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Viral pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Body tinea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Fungal skin infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Intertrigo candida</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Tinea capitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Conjunctivitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Ear lobe infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Folliculitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Genital candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Breast cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Bronchitis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Conjunctivitis infective</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Eczema infected</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Enteritis infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Enterobiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Erythema infectiosum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Gastritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Parainfluenzae virus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rash pustular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Roseola</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Viraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Otitis media chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Infected insect bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Tinea infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Varicella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Wound infection staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>External ear cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Hand-foot-and-mouth disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Lice infestation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Oral fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Viral diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rotavirus infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Burns first degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Animal bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Arthropod sting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Cardiac murmur</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Blood thyroid stimulating hormone decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Cardiac murmur functional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Head circumference abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Food intolerance</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Weight gain poor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Lactose intolerance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Torticollis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Nose deformity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Weight bearing difficulty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Premature closure of cranial sutures</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Haemangioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Benign vaginal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Haemangioma of skin</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Skin papilloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Hypersomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Hypertonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Hypokinesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Nystagmus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Speech disorder developmental</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Crying</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Restlessness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Staring</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Crystalluria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Vesicoureteric reflux</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Penile adhesion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Vulval disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Genital discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Genital erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Gynaecomastia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Penile blister</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Penis disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Testicular retraction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="28" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="39" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="9" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Bronchial hyperreactivity</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Choking</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Apnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Laryngospasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Postnasal drip</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Pharyngolaryngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="31" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dermatitis diaper</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="6" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Seborrhoeic dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Seborrhoea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dermatitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rash papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Acne infantile</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dandruff</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Drug eruption</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rash erythematous</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Blister</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Cafe au lait spots</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Intertrigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Pityriasis alba</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Post inflammatory pigmentation change</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Skin disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Skin exfoliation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Skin hyperpigmentation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Skin hypopigmentation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Umbilical erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Heat rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Keratosis pilaris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Rash rubelliform</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
              <event>
                <sub_title>Tenderness (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Tenderness (any)=present at site of vaccination.</description>
                <counts group_id="E1" subjects_affected="192" subjects_at_risk="264"/>
                <counts group_id="E2" subjects_affected="195" subjects_at_risk="270"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="121" subjects_at_risk="149"/>
                <counts group_id="E6" subjects_affected="124" subjects_at_risk="147"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Tenderness (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Tenderness (any)</description>
                <counts group_id="E1" subjects_affected="154" subjects_at_risk="200"/>
                <counts group_id="E2" subjects_affected="164" subjects_at_risk="216"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Tenderness (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Tenderness (any)</description>
                <counts group_id="E1" subjects_affected="140" subjects_at_risk="178"/>
                <counts group_id="E2" subjects_affected="140" subjects_at_risk="173"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Tenderness (Significant)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Tenderness (significant)=present and interfered with limb movement.</description>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="182"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="195"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="65"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Tenderness (Significant)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Tenderness (significant)</description>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="123"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="131"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Tenderness (Significant)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Tenderness (significant)</description>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="86"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Induration (any)=present at site of vaccination.</description>
                <counts group_id="E1" subjects_affected="55" subjects_at_risk="201"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="216"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="40" subjects_at_risk="91"/>
                <counts group_id="E6" subjects_affected="37" subjects_at_risk="73"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Induration (any)</description>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="141"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="146"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Induration (any)</description>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="116"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="103"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Mild)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Induration (mild)=0.5 centimeters (cm) to 2.0 cm.</description>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="199"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="212"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="39" subjects_at_risk="90"/>
                <counts group_id="E6" subjects_affected="33" subjects_at_risk="71"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Mild)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Induration (mild)</description>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="141"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="142"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Mild)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Induration (mild)</description>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="113"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="103"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Moderate)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Induration</description>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="193"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="68"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Moderate)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Induration (moderate)</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="118"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="126"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Moderate)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Induration (moderate)</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="82"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Severe)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Induration (severe) &gt;7.0 cm.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="187"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Severe)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Induration (severe)</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="116"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Induration (Severe)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Induration (severe)</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Erythema (any)=present at site of vaccination.</description>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="202"/>
                <counts group_id="E2" subjects_affected="72" subjects_at_risk="223"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="56" subjects_at_risk="103"/>
                <counts group_id="E6" subjects_affected="57" subjects_at_risk="87"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Erythema (any)</description>
                <counts group_id="E1" subjects_affected="70" subjects_at_risk="155"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="164"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Any)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Erythema (any)</description>
                <counts group_id="E1" subjects_affected="64" subjects_at_risk="131"/>
                <counts group_id="E2" subjects_affected="59" subjects_at_risk="118"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Mild)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Erythema (mild)=0.5 cm to 2.0 cm.</description>
                <counts group_id="E1" subjects_affected="69" subjects_at_risk="200"/>
                <counts group_id="E2" subjects_affected="69" subjects_at_risk="220"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="55" subjects_at_risk="102"/>
                <counts group_id="E6" subjects_affected="54" subjects_at_risk="85"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Mild)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Erythema (mild)</description>
                <counts group_id="E1" subjects_affected="69" subjects_at_risk="155"/>
                <counts group_id="E2" subjects_affected="60" subjects_at_risk="162"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Mild)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Erythema (mild)</description>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="128"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="117"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Moderate)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Erythema (moderate)=2.5 cm to 7.0 cm.</description>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="177"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="191"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="62"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="50"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Moderate)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Erythema (moderate)</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="117"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="124"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Moderate)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Erythema (moderate)</description>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="91"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="80"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Severe)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 1 and Toddler Dose; Erythema (severe) &gt;7.0 cm.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="173"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="59"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Severe)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Erythema (severe)</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="116"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Erythema (Severe)</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 3; Erythema (severe)</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="87"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title vocab="Systemic Events">Fever &gt;39°C but ≤40°C</sub_title>
                <assessment>Systematic Assessment</assessment>
                <description>Infant Series Dose 2; Fever &gt;39 degrees C but ≤40 degrees C</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="118"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="123"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Exposure to communicable disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="331"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="332"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="267"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="258"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="330"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="329"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pfizer ClinicalTrials.gov Call Center</name_or_title>
      <organization>Pfizer, Inc.</organization>
      <phone>1-800-718-1021</phone>
      <email>ClinicalTrials.gov_Inquiries@pfizer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

